AbbVie Investor relations：AbbVie Reports Second
AbbVie Reports Second
2024年7月25日—AbbViewillhostaninvestorconferencecalltodayat8:00a.m.CentralTimetodiscussoursecond-quarterperformance.Thecallwillbewebcast ...。其他文章還包含有：「AbbvieInvestorRelations」、「Financialreleases」、「Events」、「Presentations」、「SECfilings」、「FinancialReports」、「AbbVieReportsFirst」、「AbbVie(ABBV)InvestorRelationsMaterial」、「InvestorResources」
查看更多 離開網站
Abbvie Investor Relations
https://investors.abbvie.com
The Investor Relations website contains information about AbbVie's business for stockholders, potential investors, and financial analysts.
Financial releases
https://investors.abbvie.com
AbbVie Logo |Investors. Investor Relations. Financials · Financial Releases · SEC Filings · Annual Reports & Proxy · Resources.
Events
https://investors.abbvie.com
AbbVie to Host First Quarter 2024 Earnings Conference Call 04/26/24 8:00 am CDT Supporting Materials AbbVie Reports First-Quarter 2024 Financial Results 118.2 ...
Presentations
https://investors.abbvie.com
AbbVie Logo |Investors. Investor Relations. Financials · Financial Releases · SEC Filings · Annual Reports & Proxy · Resources · Shareholder Information · Tax ...
SEC filings
https://investors.abbvie.com
View SEC Groupings descriptions, Group 3,4,5 Annual Filings, Current Reports, Mergers & Acquisitions, Other Proxy Filings, Quarterly Filings, Registration ...
Financial Reports
https://investors.abbvie.com
View a full library of AbbVie's financial new releases. SEC filings Access all of AbbVie's SEC filings. Annual report & proxy View AbbVie's annual reports.
AbbVie Reports First
https://www.prnewswire.com
AbbVie will host an investor conference call today at 8:00 a.m. Central Time to discuss our first-quarter performance. The call will be webcast ...
AbbVie (ABBV) Investor Relations Material
https://quartr.com
Access AbbVie Inc (ABBV) Investor Relations material, such as Live Earnings Calls, Transcripts, Slides, Reports, and Estimates using Quartr.
Investor Resources
https://investors.abbvie.com
Contact information and answers to questions concerning AbbVie stock purchase, dividends, and how to contact AbbVie's transfer agent and investor relations.